ACE-083 is a follistatin-based therapeutic agent designed for localized activity that increases muscle mass by binding myostatin and related muscle-regulatory factors, and although ACE-083 demonstrated consistent muscle volume increases across multiple clinical trials, its lack of functional improvement in phase II facioscapulohumeral muscular dystrophy studies led to discontinuation of its development for FSHD.
Marketplace OffersShowing from 1 suppliers
Supplier
TargetMolSC
Pack Size
Estimated Lead Time
1-3 days
Purity
99.78%
$ 54.00
1
You cannot determine which compound library is the best fit for your project? Do you need a custom solution? AnyMol is always ready to help you.